Seres Therapeutics Inc (NASDAQ:MCRB) price on Thursday, April 10, rose 8.32% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.58.
A look at the stock’s price movement, the close in the last trading session was $0.54, moving within a range at $0.5166 and $0.59. The beta value (5-Year monthly) was 2.53. Turning to its 52-week performance, $1.53 and $0.46 were the 52-week high and 52-week low respectively. Overall, MCRB moved -16.24% over the past month.
Seres Therapeutics Inc’s market cap currently stands at around $101.24 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-12.
Turning to the stock’s technical picture we see that short term indicators suggest on average that MCRB is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend MCRB as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
MCRB’s current price about -14.74% and -21.38% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 37.54, while 7-day volatility ratio is 14.34% and 8.91% in the 30-day chart. Further, Seres Therapeutics Inc (MCRB) has a beta value of 2.89, and an average true range (ATR) of 0.06. Analysts have given the company’s stock an average 52-week price target of $1.25, forecast between a low of $1.25 and high of $1.25. Looking at the price targets, the low is -115.52% off current price level while to achieve the yearly target high, price needs to move -115.52%. Nonetheless, investors will most likely welcome a -115.52% jump to $1.25 which is the analysts’ median price.
If we refocus on Seres Therapeutics Inc (NASDAQ:MCRB), historical trading data shows that trading volumes averaged 1.06 over the past 10 days and 1.28 million over the past 3 months. The company’s latest data on shares outstanding shows there are 173.01 million shares.
The 26.90% of Seres Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 22.93% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 16.72 million on 2025-03-14, giving us a short ratio of 20.8. The data shows that as of 2025-03-14 short interest in Seres Therapeutics Inc (MCRB) stood at 1563.0000999999997 of shares outstanding, with shares short falling to 17.69 million registered in 2025-02-14. Current price change has pushed the stock -30.13% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the MCRB stock continues to rise going into the next quarter.
